Comparison of the Effectiveness of the Ultrasound Guided Subacromial, Acromioclavicular With Subacromial Injection and Suprascapular Nerve Block in Patients With Shoulder Impingement Syndrome ; A Randomized Controlled, Single Blind, Clinical Trial
Overview
- Phase
- Phase 4
- Intervention
- bupivacaine and methylprednisolone
- Conditions
- Shoulder Impingement
- Sponsor
- Bursa Yüksek İhtisas Education and Research Hospital
- Enrollment
- 88
- Primary Endpoint
- Visual Analogue Scale (VAS)
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
Shoulder pain, which is the third most common cause of musculoskeletal pain, has different etiologies. Muscle, bone structures and connective tissue pathologies can cause shoulder pain. Impingement syndrome (IS), which can cover many terms such as rotator cuff disorders, tendinitis and tears, is one of the most common pathologies of shoulder pain.
Detailed Description
The hypothesis of this study was that injection types including ACJ would increase treatment efficacy.Therefore, this study investigated the six-month follow-up results of patients undergoing SA injection and SSNB and those receiving SA and ACJ injection.
Investigators
Dr. Burcu Metin Ökmen
Principal Investigator,Assoc.Phd.M.D.
Bursa Yüksek İhtisas Education and Research Hospital
Eligibility Criteria
Inclusion Criteria
- •patients aged 18-65,
- •who were suffering from shoulder pain for more than three months and
- •who were diagnosed with IS.
- •All patients included in the study were diagnosed with IS using Shoulder Magnetic Resonance imaging.
Exclusion Criteria
- •the presence of cervical radiculopathy;
- •undergoing shoulder operation before;
- •the presence of central nervous system or
- •the presence of rheumatological disease, and polyneuropathy;
- •receiving physical therapy in the shoulder area with a diagnosis of IS within the last six months; and
- •receiving any injection therapy in the past.
Arms & Interventions
subacromial injection
ultrasound (US)-guided subacromial injection
Intervention: bupivacaine and methylprednisolone
acromioclavicular joint and subacromial injection
ultrasound (US)-guided acromioclavicular joint and subacromial injection
Intervention: bupivacaine and methylprednisolone
suprascapular nerve block
ultrasound (US)-guided suprascapular nerve block
Intervention: bupivacaine and methylprednisolone
Outcomes
Primary Outcomes
Visual Analogue Scale (VAS)
Time Frame: six month
for pain. 0: no pain at all, 10: worst pain imaginable
Secondary Outcomes
- Shoulder pain and disability index (SPADI)(six month)
- Short-Form 12 (SF-12)(six month)